Donor factors similarly impact survival outcome after liver transplantation in Hepatocellular carcinoma and non-Hepatocellular carcinoma patients

Digestive Diseases and Sciences

Volumn 59, Issue 1, 2014, Pages 214-219

  Salgia, Reena J ^a   Goodrich, Nathan P ^b   Marrero, Jorge A ^c   Volk, Michael L ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Donor factors; Hepatocellular carcinoma; Liver transplant; Survival

Indexed keywords

ADULT; AGE; ALCOHOL LIVER DISEASE; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CAUSE OF DEATH; CLINICAL ARTICLE; COLD ISCHEMIA; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FATTY LIVER; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; ORGAN DONOR; OUTCOME ASSESSMENT; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL;

EID: 84893674542     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-2883-7     Document Type: Article

References (15)

1. El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365:1118-1127.
2. Bosch FX, Ribes J, Diaz M, et al. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127:S5-S16.
3. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 2005;25:181-200.
4. Pelletier SJ, Fu S, Thyagarajan V, et al. An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data. Liver Transpl. 2009;15:859-868.
5. Zavaglia C, De Carlis L, Alberti AB, et al. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol. 2005;100:2708-2716.
6. Bertuzzo VR, Cescon M, Ravaioli M, et al. Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. Transplantation. 2011;91:1279-1285.
7. Jonas S, Bechstein WO, Steinmuller T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology. 2001;33:1080-1086.
8. Ioannou GN, Perkins JD, Carithers RL. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology. 2008;134:1342-1351.
9. Saab S, Wang V, Ibrahim AB, et al. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl. 2003;9:473-476.
10. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006;6:783-790.
11. Angelico M, Cillo U, Fagiuoli S, et al. Liver match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching. Dig Liver Dis. 2011;43:155-164.
12. El-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology. 2008;134:1752-1763.
13. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693-699.
14. Volk ML, Reichert HA, Lok ASF, et al. Variation in organ quality between liver transplant centers. Am J Transplant. 2011;11:958-964.
15. Washburn K, Edwards E, Harper A, et al. Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system. Am J Transplant. 2010;10:1643-1648.